Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for Somatostatin Receptor Positive (SSTR+)
18 locations incl. Scottsdale
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 12 - 100
Code: NCT06784752·Phase 3·Recruiting·Listed Jan 2025